Vivo Opportunity Fund Holdings, L.P. - 30 Sep 2025 SCHEDULE 13G/A Report for Unicycive Therapeutics, Inc. Common Stock, $0.001 par value per share (UNCY)

Filing Manager
Vivo Opportunity Fund Holdings, L.P.
Reporting Manager
Vivo Opportunity Fund Holdings, L.P.
Security
Unicycive Therapeutics, Inc. Common Stock, $0.001 par value per share
Symbol
UNCY
Shares outstanding
61,022,773 shares
Disclosed Ownership
6,096,175 shares
Ownership
10%
Form type
SCHEDULE 13G/A
Filing time
14 Nov 2025, 18:34:02 UTC
Date of event
30 Sep 2025
SEC
View on sec.gov

Sponsored

Quoteable Key Fact

"Vivo Opportunity Fund Holdings, L.P. disclosed 10% ownership in Unicycive Therapeutics, Inc. Common Stock, $0.001 par value per share (UNCY) on 30 Sep 2025."

Quick Takeaways

  • Vivo Opportunity Fund Holdings, L.P. filed SCHEDULE 13G/A for Unicycive Therapeutics, Inc. Common Stock, $0.001 par value per share (UNCY).
  • Disclosed ownership: 10%.
  • Date of event: 30 Sep 2025.

What Changed

  • No earlier schedule filing is available for direct comparison.
  • Current filing was accepted on 14 Nov 2025, 18:34.

Why This Matters

  • This page explains what this Schedule 13D/13G filing tells you before manager-level rows.
  • You can verify ownership claims directly against the original SEC filing.

Official SEC Source

Backed by Schedule 13D/13G

Beneficial ownership values are sourced from the original SEC Schedule 13D/13G filing.

See Original Filing

Reporting Managers (2)

Name Ownership Shares Owned sole voting power shared voting power Signature Title CIK
Vivo Opportunity Fund Holdings, L.P. 10% 6,096,175 6,096,175 0 /s/ Kevin Dai Kevin Dai/Managing Member of Vivo Opportunity, LLC, General Partner
Vivo Opportunity, LLC 10% 6,096,175 6,096,175 0 /s/ Kevin Dai Kevin Dai/Managing Member

Sponsored